highest dose of glp-1 π¨ FDA just approved Foundayoβ’ (orforglipron) β Lilly's once-daily oral GLP- 1 for obesity. The headline: 12.4% average body weight reduction at the over 72 weeks in ATTAIN-1. That's β27 lbs GLP-1 receptor agonists | How
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23


























